Skip to content
Abivax
Primary Menu
About Us
Company
Management Team
Board of Directors
Scientific Advisory Board
Science
Overview
Publications
ABTECT
Pipeline
Overview
Patients
Obefazimod in UC
Obefazimod in CD
Investors
Overview
Share Price
Investor Documents
General Meeting
Contact Us
Search
Search for:
Search
EN
FR
DE
News & Events
Press Coverage
2023
2022
2021
2020
2019
BioCentury
March 7, 2016
ABX464: Additional Phase IIa data
Reuters
February 29, 2016
Abivax updates on ABX464 study to treat HIV
Scrip
February 10, 2016
Video Interview: Armed With Promising Clinical Data, Abivax Seeks Partners
LabioTech
January 18, 2016
A Phase II HIV Antiviral from France Has Promising Results
1
2